Monalizumab
D419NC00001
Phase 2 small_molecule active
Quick answer
Monalizumab for Advanced Solid Tumors is a Phase 2 program (small_molecule) at MedImmune with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MedImmune
- Indication
- Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active